Tracking maturity of the enabling environment for clinical trials

Authors

Vasee Moorthy, World Health Organization, Geneva, Switzerland
P J Devereaux, McMaster University
Carren Sui-Lin Teh, National Institutes of Health
Indri Rooslamiati, Center for Biomedical and Genomic Health and Clinical Research Center
Ololade D. Adeyemi, Federal Ministry of Health, Abuja, Nigeria
Saeed Hamid, Aga Khan UniversityFollow
Ana Zanoletty, European Medicines Agency, Amsterdam, Netherlands
Kwasi Nyarko, World Health Organization Regional Office for Africa
Wei Zhang, World Health Organization, Geneva, Switzerland
Jeremy Farrar, World Health Organization, Geneva, Switzerland
Ibrahim Abubakar, University College London, London, UK

Document Type

Response or Comment

Department

Medicine; Gastroenterology

Abstract

Abstract is not provided by the author/publisher.

Publication (Name of Journal)

The Lancet

DOI

10.1016/S0140-6736(25)01279-6

Recommended Citation

Moorthy, V., Devereaux, P., Teh, C. S., Rooslamiati, I., Adeyemi, O. D., Hamid, S., Zanoletty, A., Nyarko, K., Zhang, W., Farrar, J., Abubakar, I. (2025). Tracking maturity of the enabling environment for clinical trials. The Lancet, 406(10499), 113-116.
Available at: https://ecommons.aku.edu/pakistan_fhs_mc_med_gastroenterol/373